SCLX: Scilex Holding Company Growth-Adjusted Market Cap to Net Income

Scilex Holding Company (SCLX) credit profile is driven by its ambition to capture the niche for safe non-opioid analgesics. This chart from the GURU.Markets portal shows that the PEG ratio remains stable, with the latest value recorded as 0.00. The financial foundation relies on the B2C pain management segment, while scaling through retail chains creates operational leverage.
Scilex (SCLX) - metric breakdowns and financial figures

The PEG ratio compares an asset's market value to its earnings growth rate, allowing for the determination of a stock's fair price relative to its expansion. By analyzing the P/E-to-growth ratio, an investor distinguishes fundamental undervaluation from stagnation risks, which is critical for Scilex Holding Company (SCLX) amid logistic disruptions and sanction restrictions affecting global drug distribution.